2-Morpholino-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinonitrile, 95.0%, 1g

6-Methoxy-1-methyl-pyrrolo[2,3-b]pyridine, 98%, 1g

2-Bromo-1-(5-fluoro-2-hydroxyphenyl)ethanone, 97.0%, 100g

Tris[2-(2-methoxyethoxy)ethyl]amine>90.0%(GC)100g

9H-fluoren-9-ylmethyl N-(2-hydroxyethyl)-N-methylcarbamate, 99.0%, 5g

9,9-Dioctyl-2,7-dibromofluorene, 98%, 500g

Ethyl 2-chloro-3-methylisonicotinate, 95.0%, 1g

(5R)-ethyl 5-((1R,3aS,7aR)-4-((E)-2-((3S,5R)-3,5-bis(tert-butyldimethylsilyloxy)-2-methylenecyclohexylidene)ethyl)-7a-methyloctahydro-1H-inden-1-yl)hexanoate, 98%, 100mg

4-BROMO-N-(4-BROMOPHENYL)-N-PHENYLANILINE, 98.0%, 500g

Methyl 2-amino-6-fluoro-3-nitrobenzoate, 98.0%, 250mg

3-Oxobutanenitrile, 95.0%, 1g

Gefitinib-based PROTAC 3, 5mg

GLIPIZIDE, 95%, 1g